Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
Abstract
Aims: Rearranged during Transfection (RET)/papillary thyroid carcinoma (PTC) and p53 are two genes involved in the pathogenesis of PTC. It has been suggested that RET/PTC expression is associated with higher rates of local extension and lymph node involvement, whereas p53 mutations are more frequent in poorly differentiated and anaplastic carcinomas. In addition, experimental studies have shown that p53 activity can modify the behaviour of PTC carrying RET/PTC. The aim of this study was to investigate the expression of both RET/PTC and p53 in order to evaluate their usefulness as prognostic factors. Methods and results: Resected specimens of 61 cases of PTC were studied immunohistochemically using a polyclonal antibody to RET and a monoclonal antibody to p53 protein. RET/PTC expression was associated with extrathyroid extension of PTC, at diagnosis (P < 0.05). In contrast, no relationship between p53 immunoreactivity and clinical status was found. In addition, p53 expression was more prevalent among RET/PTC+ patients, and significantly influenced the relationship observed between RET/PTC and extrathyroid extension of the disease. Conclusion: Our results suggest that immunohistochemistry for both PTC/RET and p53 could be useful in the clinical evaluation of patients with PTC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PTC patients with RET/PTC rearrangements or BRAFV600E mutation exhibit cell dedifferentiation.
“PTC patients with RET/PTC rearrangements [30–32] or the BRAFV600E mutation [33, 34] exhibit cell dedifferentiation.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [30]
Cites
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785 · see citing works
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
DeGroot, L. J., Kaplan, E. L., McCormick, M., & Straus, F. H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-414 · Cited by 1,045 · see citing works
Nikiforov, Y. E., Rowland, J. M., Bove, K. E., Monforte-Muñoz, H., & Fagin, J. A. (1997) · PubMed · Cited by 666 · see citing works
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., MATSUO, K., Karmakar, A., Chen, D. L., Tang, S., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 647 · see citing works
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
Fusco, A., Grieco, M., Santoro, M. M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Porta, G., & Vecchio, G. (1987) · Nature · doi:10.1038/328170a0 · Cited by 412 · see citing works
Donghi, R., Longoni, A., Pilotti, S., Michieli, P., Porta, G., & Pierotti, M. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116385 · Cited by 369 · see citing works
Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, T., Hayashi, Y., Dohi, K., Nakamura, N., & Akiyama, M. (1992) · American Journal of Otolaryngology · doi:10.1016/0196-0709(92)90038-u · Cited by 350 · see citing works
Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma
Cheung, C. C., Ezzat, S., Freeman, J. L., et al. (2001) · Modern Pathology · doi:10.1038/modpathol.3880312 · Cited by 339 · see citing works
Tallini, G., Santoro, M. M., Helie, M., Carlomagno, F., Salvatore, G., Chiappetta, G., Carcangiu, M. L., & Fusco, A. (1998) · PubMed · Cited by 302 · see citing works
Distinct MultipleRET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia1
Sugg, S. L., Ezzat, S., Rosen, I. B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5271 · Cited by 274 · see citing works
Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Porta, G., & Pierotti, M. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.358-366.1993 · Cited by 254 · see citing works
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Viglietto, G., Chiappetta, G., Martínez-Tello, F. J., Fukunaga, F., Tallini, G., Rigopoulou, D., Visconti, R., Mastro, A., Santoro, M., & Fusco, A. (1995) · PubMed · Cited by 248 · see citing works
Fenton, C., Lukes, Y. D., Nicholson, D., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6472 · Cited by 226 · see citing works
RET Oncogene Activation in Papillary Thyroid Carcinoma
Tallini, G., Asa, S. L., & Fuller, G. N. (2001) · Advances in Anatomic Pathology · doi:10.1097/00125480-200111000-00005 · Cited by 224 · see citing works
Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia
Sugg, S. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.4116 · Cited by 211 · see citing works
Bongarzone, I., Fugazzola, L., Vigneri, P. G., Mariani, L., Mondellini, P., Pacini, F., Basolo, F., Pinchera, A., Pilotti, S., & Pierotti, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626874 · Cited by 190 · see citing works
Fenton, C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1170 · Cited by 190 · see citing works
In vitro irradiation is able to cause RET oncogene rearrangement.
Ito, T., Seyama, T., Iwamoto, K. S., Hayashi, T., Mizuno, T., Tsuyama, N., Dohi, K., Nakamura, N., & Akiyama, M. (1993) · PubMed · Cited by 163 · see citing works
Overexpression of p53 as a Possible Prognostic Factor in Human Thyroid Carcinoma
Dobashi, Y., Sakamoto, A., Sugimura, H., et al. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199304000-00008 · Cited by 158 · see citing works
Ain, K. B. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30020-3 · Cited by 135 · see citing works
Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma1
Cheung, C. C., Ezzat, S., Ramyar, L., Freeman, J. L., & Asa, S. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6404 · Cited by 130 · see citing works
Basolo, F., Giannini, R., Monaco, C., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64368-4 · Cited by 116 · see citing works
RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors
Santoro, M., Papotti, M. G., Chiappetta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8174 · Cited by 113 · see citing works
Pfaff, W. W. (1998) · Head & Neck · doi:10.1002/(sici)1097-0347(199803)20:2 · Cited by 113 · see citing works
Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma
Musholt, T. J., Musholt, P. B., Khaladj, N., et al. (2000) · Surgery · doi:10.1067/msy.2000.110845 · Cited by 108 · see citing works
The ret/PTC oncogene in papillary thyroid carcinoma.
Sm, J., & Mazzaferri, E. L. (1994) · PubMed · Cited by 106 · see citing works
Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas
Perle, K. M. D. L., Jhiang, S. M., & Capen, C. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64577-4 · Cited by 105 · see citing works
Chiappetta, G., Toti, P., Cetta, F., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8180 · Cited by 103 · see citing works
Oncogene profile of papillary thyroid carcinoma
Sugg, S. L., Ezzat, S., Zheng, L., Freeman, J. L., Rosen, I. B., & Asa, S. L. (1999) · Surgery · doi:10.1016/s0039-6060(99)70287-4 · Cited by 93 · see citing works
P53 gene mutations: Case study of a clinical marker for solid tumors
Liu, M., & Gelmann, E. P. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.32900 · Cited by 85 · see citing works
Nishizuka, S., Tamura, G., Terashima, M., & Satodate, R. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199805)185:1 · Cited by 84 · see citing works
Genetic alterations in human epithelial thyroid tumours
Suarez, H. G. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00443.x · Cited by 82 · see citing works
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours
Santoro, M., Sabino, N., Ishizaka, Y., Ushijima, T., Carlomagno, F., Cerrato, A., Grieco, M., Battaglia, C., Martelli, M., Paulin, C., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.370 · Cited by 75 · see citing works
Lanzi, C., Borrello, M. G., Bongarzone, I., et al. (1992) · PubMed · Cited by 72 · see citing works
Alterations of p53 and Expression of WAF1/p21 in Human Thyroid Tumors
Zedenius, J., Larsson, C., Wallin, G., et al. (1996) · Thyroid · doi:10.1089/thy.1996.6.1 · Cited by 72 · see citing works
Santoro, M., Grieco, M., Melillo, R. M., et al. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330513 · Cited by 71 · see citing works
Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma
Cheung, C. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.878 · Cited by 68 · see citing works
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
Holm, R., & Nesland, J. M. (1994) · The Journal of Pathology · doi:10.1002/path.1711720307 · Cited by 62 · see citing works
Park, Koh, Kim, et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00515.x · Cited by 61 · see citing works
Basolo, F., Molinaro, E., Agate, L., et al. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450599 · Cited by 59 · see citing works
Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation
Fabien, N., Paulin, C., Santoro, M., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.416 · Cited by 48 · see citing works
Hosal, S. A., Apel, R. L., Freeman, J. L., et al. (1997) · Endocrine Pathology · doi:10.1007/bf02739704 · Cited by 47 · see citing works
Powell, D. J., Russell, J. P., Li, G., Kuo, B. A., Fidanza, V., Huebner, K., & Rothstein, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204425 · Cited by 46 · see citing works
Prognostic Factors in Papillary and Follicular Thyroid Carcinomas
Godballe, C., Asschenfeldt, P., Jørgensen, K. E., Bastholt, L., CLAUSEN, P. P., Hansen, T. P., Hansen, O., & Bentzen, S. M. (1998) · The Laryngoscope · doi:10.1097/00005537-199802000-00016 · Cited by 43 · see citing works
Chiappetta, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.364 · Cited by 42 · see citing works
p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas.
Matías‐Guiu, X., Cuatrecasas, M., Musulén, E., & Prat, J. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.4.337 · Cited by 39 · see citing works
P53 mutations in thyroid carcinoma: Tidings from an old foe
Farid, N. R. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343889 · Cited by 36 · see citing works
Koga, T., Hashimoto, S., Sugio, K., Yoshino, I., Nakagawa, K., Yonemitsu, Y., Sugimachi, K., & Sueishi, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4 · Cited by 34 · see citing works
Horie, S., Maeta, H., Endo, K., Ueta, T., TAKASHIMA, K., & Terada, T. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01159.x · Cited by 32 · see citing works
The radiographic diagnosis and treatment of paraneoplastic central nervous system disease
Glantz, M., Biran, H., Myers, M. E., Gockerman, J. P., & Friedberg, M. H. (1994) · Cancer · doi:10.1002/1097-0142(19940101)73:1 · Cited by 31 · see citing works
nm23-H1 Immunoreactivity as a Prognostic Factor in Differentiated Thyroid Carcinoma
Zafón, C., Obiols, G., Castellví, J., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7710 · Cited by 28 · see citing works
Self-citationret/PTC expression may be associated with local invasion of thyroid papillary carcinoma
Miki, H., Kitaichi, M., Masuda, E., et al. (1999) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199906)71:2 · Cited by 25 · see citing works
Goto, A., Sakamoto, A., & Machinami, R. (2001) · Pathology - Research and Practice · doi:10.1078/0344-0338-00037 · Cited by 21 · see citing works
Significance of P53 in human thyroid tumors
Simon, D., Goretzki, P. E., Goreley, V., et al. (1994) · World Journal of Surgery · doi:10.1007/bf00353758 · Cited by 20 · see citing works
Tumor suppressor genes: A short review
Yeo, C. J. (1999) · Surgery · doi:10.1016/s0039-6060(99)70001-2 · Cited by 17 · see citing works
Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma
Park, Y.-K., Park, H. Y., Chi, S.-G., et al. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.353 · Cited by 13 · see citing works
Mai, K. T., Vaccani, J. P., Thomas, J., et al. (2001) · Thyroid · doi:10.1089/105072501316973118 · Cited by 9 · see citing works
nm23-H1 Immunoreactivity as a Prognostic Factor in Differentiated Thyroid Carcinoma
Zafón, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3975 · Cited by 9 · see citing works
Martínez, I. G., Mantilla, A., Medrano, M. E., et al. (2001) · Endocrine Pathology · doi:10.1385/ep:12:2:113 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chen, H., Luo, D., Zhang, L., Lin, X., Luo, Q., Yi, H., Wang, J., Yan, X., Li, B., Chen, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17398 · Cited by 29 · see citing works
- Authors
- Zafon, C., Obiols, G., Castellví, J., Tallada, N., Baena, J. A., Simó, R., & Mesa, J.
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Corresponding author
- Obiols, G
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 50
- Issue
- 2
- Pages
- 225-231
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2087000480
- Cited by
- 31
- References
- 59
- Citations by year
- 2023: 2 · 2022: 2 · 2019: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Histopathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Keywords
- papillary thyroid carcinoma, RET/PTC rearrangement, p53 expression, prognostic factors, extrathyroidal extension, lymph node metastasis, RET oncogene, TP53 mutation, immunohistochemistry
- MeSH terms
- Adult, Carcinoma, Female, Humans, Male, Prognosis, Thyroid Neoplasms, Biomarkers, Tumor, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-ret
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review